Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: High-intensity Exercise After Treatment [NA]
This clinical trial investigating high-intensity exercise after breast cancer treatment was terminated.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating an omega-3 fatty acid-based anti-cancer therapy in patients with metastatic triple-negative inflammato…
-
FDA approval · 2024-09-03FDA Approved: KISQALI FEMARA CO-PACK — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application to authorize the Kisqali-Femara co-pack (ribociclib and letrozole) by Novartis, enabling combination…
-
FDA approval · 2024-09-03FDA Approved: KISQALI — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Kisqali (ribociclib) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance
A completed NHGRI-supported clinical study examining Latinas' causal beliefs about breast and colon cancer and different models of inherited…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors [Phase 1]
Phase 1 dose-escalation study of PF-06804103 in HER2-positive and HER2-negative solid tumors (part 2 negative) in breast cancer; the trial (…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle Pain [NA]
Clinical trial update reporting completion of a study evaluating the Tonation Breathing Technique to ease aromatase inhibitor–induced joint …
-
EMA approval · 2024-08-30EMA Authorised: Iasibon (ibandronic acid) — Pharmathen S.A.
EMA authorised Iasibon (ibandronic acid) for hypercalcemia, prevention of bone fractures, and cancer-related indications involving metastati…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Use of Artificial Intelligence in the Symptomatic BReAst Clinic SEtting
An update on a clinical trial investigating the use of artificial intelligence in the symptomatic breast clinic setting.
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast Cancer [NA]
A clinical trial sponsored by Roswell Park Cancer Institute evaluating mindfulness-based stress reduction for metastatic breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2024-08-30Clinical Trial Update: Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer [Phase 1]
Phase 1 clinical trial assessing the combination of anlotinib with trastuzumab deruxtecan for previously treated HER2-low advanced breast ca…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer [Phase 2]
Phase 2 study to prevent rash in people starting alpelisib for breast cancer was terminated. Results were posted in 2024.
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd [Phase 2]
A Phase 2 clinical trial evaluating ARX-788 in HER2-positive metastatic breast cancer patients who previously received trastuzumab deruxteca…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer [Phase 4]
Phase 4 clinical trial evaluating Inetetamab with Paclitaxel, with or without Pertuzumab, for previously treated HER2-positive metastatic br…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Lifestyle Behavioural Intervention on Breast Cancer Survivors for the Treatment of Overweight/Obesity. [NA]
This clinical trial evaluates a lifestyle behavioural intervention for overweight or obese breast cancer survivors and is not yet recruiting…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease [Phase 2]
Phase 2 trial evaluating deslorelin with low-dose add-back estradiol and testosterone to prevent breast cancer in premenopausal women at hig…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Under- and Overdiagnosis in BreastScreen Norway
A completed clinical trial update from the Norwegian Institute of Public Health examining under- and overdiagnosis in the BreastScreen Norwa…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Mind Programme for Women With Breast Cancer [NA]
A clinical trial update indicates a Mind Programme for women with breast cancer is currently recruiting at the University of Coimbra; no tri…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision
A prospective clinical study evaluating EnVisio Spatial Intelligence for soft tissue localization and guided surgical excision in breast tum…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making [NA]
Results have been posted for a clinical trial aimed at increasing patient engagement in breast cancer surgery decision-making, involving Sta…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Motiva Flora Tissue Expander PMCF [NA]
Clinical trial update for Motiva Flora Tissue Expander PMCF (NCT05447988) showing the study is currently recruiting for breast tissue and br…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women [NA]
The Cedars-Sinai Medical Center-sponsored study is recruiting Korean women to evaluate a church-based navigation model aimed at increasing b…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction
A completed retrospective data collection study evaluating Motiva Flora TE in breast reconstruction for breast cancer patients. The trial is…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Breast Cancer and Metastatic Lymph Nodes [NA]
This clinical trial update concerns how long indocyanine green remains in axillary lymph nodes after subdermal injection in patients with br…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Group Therapy for Primary Breast Cancer [Phase 3]
This is a completed Phase 3 clinical trial evaluating group therapy for patients with primary breast cancer.